Fast-tracking COVID-19 vaccine approval
The story grabbing all the attention in October was the piece on Moderna engaging with international regulators to accelerate approval of its experimental COVID-19 vaccine - mRNA-1273.
The developer's rolling submission was accepted under the Canadian Minister of Health's Interim Order, which permits companies to present safety and efficacy data and information as they become available, without waiting for studies to end. Such an approach to reviews could speed up the process of approving a successful COVID-19 vaccine.
The company also announced that its application for real-time review of mRNA-1273 in Europe had been accepted by the European Medicines Agency (EMA).
Top five stories from October Fast-tracking COVID-19 vaccine approval Novel nasal therapy hopes to reduce the amount of COVID-19 virus reaching the lungs COVID-19 vaccines - the race to the front Five key takeaways from 10 months of COVID-19 vaccine work Repurposing the BCG vaccine